empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Especialista em análise na InstaForex
© 2007-2025
Selecionar intervalo de tempo
5
min
15
min
30
min
1
hora
4
horas
1
dia
1
s.
Ganhe com as variações das taxas das criptomoedas com a InstaForex.
Baixe o MetaTrader 4 e abra a sua primeira operação.
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    PARTICIPE DO CONCURSO

Recommended Stories

Resumo de notícias do mercado dos EUA para 17 de março

Os principais índices acionários dos EUA, como o S&P 500 e o Nasdaq, encerraram a semana em território positivo, impulsionados por avanços encorajadores nas negociações comerciais com a China

Ekaterina Kiseleva 16:30 2025-05-05 UTC+2

Europa em pausa: O que está por trás da queda do mercado de ações e da atividade inesperada de Trump

As ações europeias caíram ligeiramente; STOXX 600 - menos 0,1%, França - menos 0,3% Os investidores aguardam dados sobre as negociações entre EUA e China, lucros e decisão

Thomas Frank 14:22 2025-05-05 UTC+2

Resumo de notícias do mercado dos EUA para 2 de maio

Os índices de ações dos EUA continuam a subir, apesar da persistente incerteza econômica. O otimismo dos investidores é impulsionado pelas expectativas de progresso nas negociações comerciais entre

Ekaterina Kiseleva 18:19 2025-05-02 UTC+2

Resumo de notícias do mercado dos EUA para 1º de maio

O mercado acionário dos EUA registrou uma volatilidade notável em abril, mas uma recuperação bem-sucedida ajudou os principais índices a recuperar as perdas. Apesar de os dados mostrarem uma contração

Ekaterina Kiseleva 15:25 2025-05-01 UTC+2

Festa durante a tempestade: S&P 500 comemora ganhos enquanto o dólar se afoga e a China enfraquece

S&P 500 registra o sexto dia consecutivo de ganhos Petróleo cai mais de 1% Atividade manufatureira da China despenca à medida que as tarifas de Trump continuam a pressionar Dólar

Thomas Frank 18:24 2025-04-30 UTC+2

Resumo de notícias do mercado dos EUA para 30 de abril

Os índices acionários dos EUA seguem uma trajetória positiva, mas a pressão no mercado aumentou devido à forte queda nas ações da Super Micro e à proximidade da divulgação

Ekaterina Kiseleva 18:09 2025-04-30 UTC+2

O otimismo retorna aos mercados: onde procurar novos pontos de crescimento?

As ações europeias subiram em meio a esperanças de uma redução nas tensões comerciais entre os EUA e a China. O petróleo WTI caiu 1,54%, para US$ 62,05

Thomas Frank 17:48 2025-04-29 UTC+2

Resumo de notícias do mercado dos EUA para 29 de abril

O S&P 500 e o Nasdaq continuam sua trajetória de alta, mantendo o impulso, apesar dos desempenhos mistos observados em outros setores. A retórica mais suave da administração Trump

Ekaterina Kiseleva 17:10 2025-04-29 UTC+2

Os mercados de ações estão recuperando o otimismo. Onde encontrar novos pontos de entrada

Os índices norte-americanos S&P 500 e Dow encerraram a sessão de segunda-feira em território positivo, apesar da elevada volatilidade nos mercados. Os investidores acompanharam de perto os sinais de progresso

14:44 2025-04-29 UTC+2

Os primeiros 100 dias de Trump já passaram: Mercados aguardam tarifas e lucros de gigantes

Resumos das políticas de Trump As ações europeias subiram na segunda-feira, após um segundo ganho semanal consecutivo Os investidores estão de olho nas mudanças tarifárias, bem como em uma semana

Thomas Frank 17:22 2025-04-28 UTC+2
Não pode falar agora?
Faça sua pergunta no chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.